HNDG4MAG-36K
MILLIPLEX® Human Neurodegenerative Disease Panel
Configurable Human Neurodegenerative Disease 5-Plex Panel 4
この商品について
製品名
MILLIPLEX® Human Neurodegenerative Disease Panel,
Quality Segment
description
Configurable Human Neurodegenerative Disease 5-Plex Panel 4
species reactivity
human
packaging
pkg of 1 ea
manufacturer/tradename
Milliplex®
assay range
accuracy: 84-108%, standard curve range: 14-10,000 pg/mL
(S100B), standard curve range: 21-15,000 pg/mL
(sRAGE), standard curve range: 27-20,000 pg/mL
(Amyloid β42), standard curve range: 3-2,500 pg/mL
(Amyloid β40), standard curve range: 7-5,000 pg/mL
(GDNF)
technique(s)
multiplexing: suitable
input
cerebrospinal fluid(s) (CSF)
detection method
fluorometric (Luminex® xMAP® technology)
shipped in
wet ice
storage temp.
2-8°C
General description
Application
Analytes included: S100B, Amyloid β40 (Aβ40), Amyloid β42 (Aβ42), sRAGE, GDNF.
Note: Serum and plasma are not verified sample types for this assay.
Assay Characteristics: Refer to kit protocol for assay cross-reactivity, sensitivity, precision, and accuracy.
Features and Benefits
- Comprehensive Alzheimer′s Pathway Coverage: Simultaneously quantify amyloid-beta peptides, S100B neuroinflammation marker, sRAGE receptor, and GDNF neuroprotective factor, providing complete insight into key Alzheimer′s disease mechanisms in one assay.
- CSF-Optimized Excellence: Specifically verified for cerebrospinal fluid analysis with exceptional spike recovery (84-108%), ensuring accurate quantification of these critical brain-derived biomarkers in precious CSF samples.
- Streamlined Neuroscience Discovery: Eliminate the complexity of five separate assays with our integrated multiplex format, accelerating your Alzheimer′s research while maximizing the utility of limited CSF samples for comprehensive biomarker profiling.
- Target Discovery Power: Leverage biomarkers spanning amyloid aggregation, neuroinflammation, and neuroprotection pathways to identify therapeutic interventions targets.
- Precision-Engineered Reliability: Trust in < 10% intra-assay precision across all analytes and < 15% inter-assay variability, delivering the data consistency essential for breakthrough neurodegenerative research.
Legal Information
Disclaimer
Label License/Sticker for Assay Product:
By opening the packaging containing this Assay Product (which contains fluorescently labeled microsphere beads authorized by Luminex Corporation) or using this Assay Product in any manner, you are consenting and agreeing to be bound by the End User Terms and Conditions and the End User License Agreement available at http://support.diasorin.com/end-user-terms-and-conditions/. If you do not agree to all of the terms and conditions, you must promptly return this Assay Product for a full refund prior to using it in any manner.
Still not finding the right product?
Explore all of our products under MILLIPLEX® Human Neurodegenerative Disease Panel
signalword
Danger
Hazard Classifications
Acute Tox. 3 Dermal - Acute Tox. 4 Inhalation - Acute Tox. 4 Oral - Aquatic Chronic 2 - Skin Sens. 1
保管分類
6.1C - Combustible acute toxic Cat.3 / toxic compounds or compounds which causing chronic effects
wgk
WGK 3
適用法令
試験研究用途を考慮した関連法令を主に挙げております。化学物質以外については、一部の情報のみ提供しています。 製品を安全かつ合法的に使用することは、使用者の義務です。最新情報により修正される場合があります。WEBの反映には時間を要することがあるため、適宜SDSをご参照ください。
Please refer to KIT Component information
pdsc
Please refer to KIT Component information
prtr
Please refer to KIT Component information
fsl
Please refer to KIT Component information
ishl_indicated
Please refer to KIT Component information
ishl_notified
Please refer to KIT Component information
cart
キットコンポーネントの情報を参照してください
jan
試験成績書（COA）
製品のロット番号・バッチ番号を入力して、試験成績書（COA） を検索できます。ロット番号・バッチ番号は、製品ラベルに「Lot」または「Batch」に続いて記載されています。